Literature DB >> 23313581

Vasopressin modulates neural responses related to emotional stimuli in the right amygdala.

Claudia Brunnlieb1, Thomas F Münte, Claus Tempelmann, Marcus Heldmann.   

Abstract

The neuropeptide vasopressin has been shown to modulate social and affective processes. Using fMRI we investigated the influence of intranasal vasopressin (AVP) on neural activations related to social cognitions and emotion processing in a group of healthy young men. In a double-blind, placebo controlled between groups design, 20 IU AVP were administered intranasally to half of the participants before scanning, while the other half received saline intranasally. All participants viewed line drawings depicting either one or two persons (social factor) in an emotionally neutral or negative scene (emotional factor). Vasopressin modulated the activation of the right amygdala related to the emotional component of empathy. Moreover, vasopressin also increased connectivity of the right amygdala with the medial prefrontal cortex (mPFC) and the inferior parietal lobule during the processing of pictures illustrating a socially threatening scene. This suggests that AVP reduces suppressive effects of the mPFC on amygdala activity resulting in the observed enhanced neural pattern in the amygdala. At present, it remains unclear whether the increased amygdala activity reflects a direct impact of AVP on vasopressin V1 receptors in the amygdala or an indirect effect via vasopressin V1 receptors in the mPFC or other remote brain sites.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313581     DOI: 10.1016/j.brainres.2013.01.009

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

1.  Neuroticism modulates the effects of intranasal vasopressin treatment on the neural response to positive and negative social interactions.

Authors:  Chunliang Feng; Ashley C DeMarco; Ebrahim Haroon; James K Rilling
Journal:  Neuropsychologia       Date:  2015-05-12       Impact factor: 3.139

2.  Association between AVPR1A, DRD2, and ASPM and endophenotypes of communication disorders.

Authors:  Catherine M Stein; Barbara Truitt; Fenghua Deng; Allison Avrich Ciesla; Feiyou Qiu; Peronne Joseph; Rekha Raghavendra; Jeremy Fondran; Robert P Igo; Jessica Tag; Lisa Freebairn; H Gerry Taylor; Barbara A Lewis; Sudha K Iyengar
Journal:  Psychiatr Genet       Date:  2014-10       Impact factor: 2.458

3.  Effects of Oxytocin and Vasopressin on Preferential Brain Responses to Negative Social Feedback.

Authors:  Marta Gozzi; Erica M Dashow; Audrey Thurm; Susan E Swedo; Caroline F Zink
Journal:  Neuropsychopharmacology       Date:  2016-10-31       Impact factor: 7.853

4.  Acute lesions that impair affective empathy.

Authors:  Richard Leigh; Kenichi Oishi; John Hsu; Martin Lindquist; Rebecca F Gottesman; Samson Jarso; Ciprian Crainiceanu; Susumu Mori; Argye E Hillis
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

5.  Critical role of the right uncinate fasciculus in emotional empathy.

Authors:  Kenichi Oishi; Andreia V Faria; John Hsu; Donna Tippett; Susumu Mori; Argye E Hillis
Journal:  Ann Neurol       Date:  2014-11-21       Impact factor: 10.422

6.  White matter tracts critical for recognition of sarcasm.

Authors:  Cameron L Davis; Kenichi Oishi; Andreia V Faria; John Hsu; Yessenia Gomez; Susumu Mori; Argye E Hillis
Journal:  Neurocase       Date:  2015-03-25       Impact factor: 0.881

7.  Limbic Neuropeptidergic Modulators of Emotion and Their Therapeutic Potential for Anxiety and Post-Traumatic Stress Disorder.

Authors:  Paul J Marvar; Raül Andero; Rene Hurlemann; Tiffany R Lago; Moriel Zelikowsky; Joanna Dabrowska
Journal:  J Neurosci       Date:  2021-01-20       Impact factor: 6.167

Review 8.  Inability to empathize: brain lesions that disrupt sharing and understanding another's emotions.

Authors:  Argye E Hillis
Journal:  Brain       Date:  2013-11-30       Impact factor: 13.501

Review 9.  Vasopressin and oxytocin receptor systems in the brain: Sex differences and sex-specific regulation of social behavior.

Authors:  Kelly M Dumais; Alexa H Veenema
Journal:  Front Neuroendocrinol       Date:  2015-05-04       Impact factor: 8.606

10.  The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study.

Authors:  Tiffany R Lago; Michael J Brownstein; Emily Page; Emily Beydler; Adrienne Manbeck; Alexis Beale; Camille Roberts; Nicholas Balderston; Eve Damiano; Suzanne L Pineles; Neal Simon; Monique Ernst; Christian Grillon
Journal:  Psychopharmacology (Berl)       Date:  2021-05-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.